These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6531624)

  • 21. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 22. [Significance of hepatitis B antigens].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):172-5. PubMed ID: 868091
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers.
    Noppornpanth S; Sathirapongsasuti N; Chongsrisawat V; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):419-21. PubMed ID: 11127351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Carriers of HBV].
    Bedarida G; Cambiè G; D'Agostino F; Arcidiacono I
    Riv Emoter Immunoematol; 1985; 32(2):168-82. PubMed ID: 4089468
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
    Ren F; Li H; Zhao H
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening.
    Allain JP
    Vox Sang; 2007 Apr; 92(3):254-7. PubMed ID: 17348876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Infectivity of hepatitis B].
    Gerken G
    Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
    [No Abstract]   [Full Text] [Related]  

  • 31. Ways of post-transfusion hepatitis prevention.
    Pintera J
    Czech Med; 1989; 12(3):149-57. PubMed ID: 2509173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical variants of acute delta infection].
    Ketiladze ES; Khlopova IN; Bugaeva NP
    Klin Med (Mosk); 1988 Aug; 66(8):95-9. PubMed ID: 3193743
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the prevalence of serum markers of hepatitis B virus in hospital personnel and in populations with a different endemicity for this virus].
    Ferrari S; Ballardini P; Landi P; Ventura S; Bonazzi C; Volta U; Busachi CA
    Boll Soc Ital Biol Sper; 1987 Feb; 63(2):177-80. PubMed ID: 2956975
    [No Abstract]   [Full Text] [Related]  

  • 38. [Distribution of hepatitis B virus in testicle tissue in patients with hepatitis B infection].
    Lang ZW
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):329-31, 379. PubMed ID: 8258099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential clinical diagnostic parameters of acute hepatitis B and flare of chronic HBV infection].
    Zhao H; Tian GS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):363-5. PubMed ID: 15650791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues.
    Chen L; Liu F; Fan X; Gao J; Chen N; Wong T; Wu J; Wen SW
    Int J Infect Dis; 2009 Jan; 13(1):20-3. PubMed ID: 18539066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.